(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 05, 2026 (GLOBE NEWSWIRE) -- "Ejection Fraction Market Size, Share & Trends Analysis Report by Application, Technology, Device, End Use, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering. The global ejection fraction market was valued at approximately USD 6.3 billion in 2025 and is projected to reach USD 12.4 billion by 2033. The market is expected to expand at a compound annual growth rate of 8.0% from 2026 to 2033, supported by the increasing prevalence of heart failure and other cardiovascular diseases worldwide.
Growing demand for regular, accurate cardiac function assessment is accelerating the adoption of ejection fraction monitoring devices and advanced diagnostic imaging systems. Healthcare providers are increasingly using these solutions to support disease diagnosis, treatment planning, therapy evaluation, and long-term patient management.
Technological innovation remains a major driver of ejection fraction market growth. Advances in non-invasive imaging technologies, including AI-enabled echocardiography and cardiac MRI, are improving measurement accuracy, clinical consistency, and workflow efficiency. AI Enabled EF Measurement solutions are also helping healthcare professionals streamline image interpretation and strengthen decision-making across cardiac care settings.
The growing adoption of remote cardiac monitoring solutions and integration with hospital information systems is further expanding the market. Connected cardiac monitoring devices and wearables can support continuous patient management, improve access to relevant clinical data, and facilitate earlier identification of cardiac deterioration. These capabilities are particularly important for heart failure management and the monitoring of patients with chronic or high-risk cardiovascular conditions.
Market Segmentation Covered in the Report
The report provides global, regional, and country-level revenue analysis, market forecasts, and trend assessments for the period from 2021 to 2033. The global ejection fraction market is evaluated by device type, technology, application, end use, and region.
Device type: Echocardiography Systems, including 2D echocardiography, 3D/4D echocardiography, and Doppler imaging systems; Cardiac MRI Systems; Cardiac CT Systems; Nuclear Imaging Systems (MUGA scanners); Implantable Cardiac Devices (ICD, CRT, VAD); and Cardiac Monitoring Devices & Wearables. Technology: Ultrasound Based, Magnetic Resonance Based, CT Based, Nuclear Imaging Based, and AI Enabled EF Measurement. Application: Heart Failure Management, Cardiomyopathy & Ischemic Heart Disease, Valvular Heart Disease, Oncology Cardiac Monitoring, and Surgical & Critical Care Assessment. End use: Hospitals, Ambulatory Care Centers, and Others.
Regional Market Coverage
The regional analysis examines market performance and growth opportunities across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America: U.S., Canada, and Mexico. Europe: UK, Germany, France, Italy, Spain, Denmark, Sweden, and Norway. Asia Pacific: Japan, China, India, Australia, South Korea, and Thailand. Latin America: Brazil and Argentina. Middle East & Africa: South Africa, Saudi Arabia, UAE, and Kuwait.
Strategic Value of the Report
The report delivers comprehensive ejection fraction market intelligence to support investment planning, product development, competitive positioning, and business expansion. It assesses major market drivers, emerging technologies, growth opportunities, regional revenue potential, and evolving demand across clinical applications.
Detailed market estimates and forecasts across major segments and regions. Analysis of key trends influencing the future of cardiac imaging and EF monitoring. Competitive landscape insights, including the market presence and strategic positioning of key participants. Segment and regional revenue forecasts for market assessment and opportunity identification. Market share and competition strategy analysis to support informed decision-making. Coverage of product innovation and technology developments shaping cardiac diagnostics. Actionable recommendations designed to identify potential revenue streams and guide strategic business decisions.
With cardiovascular disease continuing to create substantial demand for accurate cardiac assessment, the ejection fraction market is positioned for sustained growth. Continued innovation in AI-enabled imaging, remote monitoring, connected devices, and clinical system integration is expected to strengthen adoption across hospitals, ambulatory care centers, and other healthcare environments through 2033.
Key Attributes
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment